Get started
VENUS MEDTECH HANGZHOU INC.VENUS MEDTECH HANGZHOU INC.VENUS MEDTECH HANGZHOU INC.

VENUS MEDTECH HANGZHOU INC.

No trades
See on Supercharts
OverviewFinancialsNewsMindsTechnicalsSeasonals

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪134.26 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.2023 USD
Net income (FY)
‪−99.66 M‬ USD
Revenue (FY)
‪65.69 M‬ USD
Shares float
‪394.36 M‬
Beta (1Y)
0.54

Employees


Employees (FY)
691
Change (1Y)
−174 −20.12%
Revenue / Employee (1Y)
‪95.06 K‬ USD
Net income / Employee (1Y)
‪−144.22 K‬ USD

About Venus Medtech (Hangzhou), Inc. Class H


Sector
Health Technology
Industry
Medical Specialties
CEO
Hou-Sen Lim
Website
venusmedtech.com
Headquarters
Wanchai
Founded
2009
ISIN
CNE100003PJ8
FIGI
BBG00Z1W7XK8
Venus Medtech (Hangzhou), Inc. provides transcatheter heart valve medical device. It engages in the research and development of cardiac intervention system for heart diseases. The company offers pre-implanted invasive heart valve systems such as transcatheter artery and pulmonary artery valve systems, and delivery catheter systems. The company was founded on July 3, 2009 and is headquartered in Hangzhou, China.

Check out other big names from the same industry as VMTHF.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of VMTHF is 0.2980 USD — it has decreased by −2.74% in the past 24 hours. Watch VENUS MEDTECH HANGZHOU INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange VENUS MEDTECH HANGZHOU INC. stocks are traded under the ticker VMTHF.
VMTHF reached its all-time high on Jan 27, 2021 with the price of 11.0717 USD, and its all-time low was 0.0108 USD and was reached on Apr 8, 2024. View more price dynamics on VMTHF chart.
See other stocks reaching their highest and lowest prices.
VMTHF stock is 5.91% volatile and has beta coefficient of 0.54. Track VENUS MEDTECH HANGZHOU INC. stock price on the chart and check out the list of the most volatile stocks — is VENUS MEDTECH HANGZHOU INC. there?
Today VENUS MEDTECH HANGZHOU INC. has the market capitalization of ‪133.28 M‬, it has decreased by −5.31% over the last week.
Yes, you can track VENUS MEDTECH HANGZHOU INC. financials in yearly and quarterly reports right on TradingView.
VENUS MEDTECH HANGZHOU INC. is going to release the next earnings report on Mar 27, 2026. Keep track of upcoming events with our Earnings Calendar.
VMTHF earnings for the last half-year are −0.04 USD per share, whereas the estimation was −0.05 USD, resulting in a 11.43% surprise. The estimated earnings for the next half-year are −0.04 USD per share. See more details about VENUS MEDTECH HANGZHOU INC. earnings.
VENUS MEDTECH HANGZHOU INC. revenue for the last half-year amounts to ‪26.11 M‬ USD, despite the estimated figure of ‪40.20 M‬ USD. In the next half-year revenue is expected to reach ‪61.64 M‬ USD.
VMTHF net income for the last half-year is ‪−18.44 M‬ USD, while the previous report showed ‪−70.89 M‬ USD of net income which accounts for 73.99% change. Track more VENUS MEDTECH HANGZHOU INC. financial stats to get the full picture.
No, VMTHF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 8, 2025, the company has 691 employees. See our rating of the largest employees — is VENUS MEDTECH HANGZHOU INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VENUS MEDTECH HANGZHOU INC. EBITDA is ‪−31.19 M‬ USD, and current EBITDA margin is −58.38%. See more stats in VENUS MEDTECH HANGZHOU INC. financial statements.
Like other stocks, VMTHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VENUS MEDTECH HANGZHOU INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VENUS MEDTECH HANGZHOU INC. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VENUS MEDTECH HANGZHOU INC. stock shows the buy signal. See more of VENUS MEDTECH HANGZHOU INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.